Miscellaneous

Home / Resources / Posters Poster Advancing mast cell research with a standardized human primary cell platform Chenyan Wu1, Cyprien Pecalvel1, Anthony David1 and Nicolas Gaudenzio1,2 1Genoskin SAS, 2INSERM UMR1291 - CNRS UMR5051, University Toulouse III Understanding mast cell activation in a human-relevant context Mast cells play a central role in immune regulation, inflammation and allergic responses, making them highlyRead more

Genoskin & argenx showcasehuman-based NAM platformPress releaseGenoskin presents translational human-based NAM platform at SOT 2026 in collaboration with argenxAdvancing New Approach Methodologies (NAMs) with human skin modelsAt the 2026 annual meeting of the Society Of Toxicology (SOT), we will present new data demonstrating the value of our HypoSkin® ex vivo human skin platform as a translational human-based New Approach MethodologyRead more

Top-level science through the eyes of an expert.Preclinical evaluation of an energy-driven device for localized skin delivery of nucleic acidsJoin us for the next session in Genoskin’s webinar series, where we explore how an energy-driven, microneedle-based device enables localized, non-viral delivery of naked nucleic acids to skin, with preclinical in vivo and ex vivo data highlighting transgene expression, immune activation,Read more

You’ll receive your pilot study plan and quote shortly by email.

Conferences & eventsCome & meet our amazing teamGenoskin at The American Academy of Allergy, Asthma, & Immunology (AAAAI) Annual Meeting 2026Enabling non-clinical immune assessment through ex vivo human skin and mast cell models Genoskin is excited to announce its participation in the American Academy of Allergy, Asthma, & Immunology (AAAAI) Annual Meeting, one of the world’s leading scientific gatherings dedicatedRead more

Media kit & brand assetsDownload Genoskin's media kit Get a copy of Genoskin's media kit. This document will provide you with all the information regarding Genoskin's activities, executive team and past media coverage. Please fill in the form below to access the media kit. Need more info? Please contact us! Contact us